Overview

Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor

Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The current trial will compare the protective effect of ticagrelor and prasugrel on microvascular dysfunction in patients with revascularized ST elevation myocardial infarction.
Phase:
Phase 4
Details
Lead Sponsor:
VU University Medical Center
Collaborators:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Erasmus Medical Center
Hospital San Carlos, Madrid
Medisch Spectrum Twente
University Medical Center Nijmegen
Treatments:
Prasugrel Hydrochloride
Ticagrelor